Differentiated T Lymphocytes and Cancer Cell Mitochondrial Metabolism to Enhance Radioimmunotherapy by a Biomimetic Nanozyme System
Advanced Science · 2026
DOI: 10.1002/advs.202515097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Hanyu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology Surgery, Harbin Medical University Cancer Hospital, Harbin, 150000, China. Hauptthemen laut MEDLINE: Mitochondria, T-Lymphocytes, Radioimmunotherapy, Biomimetic Materials. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangxi Young Elite Scientist Sponsorship Program, Heilongjiang Province Natural Science Outstanding Youth Program.
Abstract (Originalsprache)
Strategies to enhance the anti‐tumor immune response through the regulation of cellular metabolism are under intensive investigation. Herein, a T cell membrane (TCM)‐coated biomimetic magnesium carbonate (MgCO 3 )/Fe‐CD hybrid nanozyme system loaded with the Pyruvate kinase M2 (PKM2) activator TEPP‐46 (TFMP) is developed, designed to simultaneously induce mitochondrial metabolic reprogramming in both T cells and tumor cells following radiotherapy (RT). The TCM coating enables TFMP to specifically target tumor tissues that highly express PD‐L1, where it competitively binds to PD‐L1 and thereby alleviates immune checkpoint‐mediated T cell suppression. Upon X‐ray irradiation, TFMP continuously catalyzes the conversion of radiotherapy‐generated hydrogen peroxide into hydroxyl radicals, thereby sustaining reactive oxygen species production, which leads to mitochondrial damage and immunogenic cell death in tumor cells. Moreover, TFMP can neutralize the acidic tumor microenvironment, while the released Mg 2+ and TEPP‐46 further augment T cell activation and mitochondrial function, thereby increasing the production of ATP and granzyme B, which effectively eliminate residual tumor cells. Experimental results demonstrate that the combination of TFMP and RT can significantly inhibit tumor progression and activate anti‐tumor immunotherapy. This TFMP enhances the efficacy of breast cancer radioimmunotherapy, offering a foundation for developing more comprehensive therapeutic approaches of breast cancer to achieve clinical benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology Surgery, Harbin Medical University Cancer Hospital, Harbin, 150000, China.
- Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China.
- Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.
- Research Center of Nanomedicine Technology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.
- NHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, 150081, China.
ORCID-Profile: Shipeng Ning
Förderung
- National Natural Science Foundation of China
- Guangxi Young Elite Scientist Sponsorship Program
- Heilongjiang Province Natural Science Outstanding Youth Program
Zitieren
APA
Zhang, H., Deng, Y., Lu, Y., Wang, M., Qiao, K., Yang, Z., Ning, S., & Liu, T. (2026). Differentiated T Lymphocytes and Cancer Cell Mitochondrial Metabolism to Enhance Radioimmunotherapy by a Biomimetic Nanozyme System. Advanced Science. https://doi.org/10.1002/advs.202515097
Vancouver
Zhang H, Deng Y, Lu Y, Wang M, Qiao K, Yang Z, et al. Differentiated T Lymphocytes and Cancer Cell Mitochondrial Metabolism to Enhance Radioimmunotherapy by a Biomimetic Nanozyme System. Advanced Science. 2026. doi:10.1002/advs.202515097
BibTeX
@article{Zhang2026,
author = {Zhang, Hanyu and Deng, Yuhan and Lu, Yantong and Wang, Miao and Qiao, Kun and Yang, Zifan and Ning, Shipeng and Liu, Tong},
title = {Differentiated T Lymphocytes and Cancer Cell Mitochondrial Metabolism to Enhance Radioimmunotherapy by a Biomimetic Nanozyme System},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202515097}
}
EUVIMED